T-cell responses against CD19(+) pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts

T-cell immunotherapies are promising options in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL). We investigated the effect of co-signaling molecules on T-cell attack against leukemia mediated by CD19/CD3-bispecific T-cell engager. Primary CD19(+) ALL blasts (n≥10) and physiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Feucht, Judith, Kayser, Simone, Gorodezki, David, Hamieh, Mohamad, Döring, Michaela, Blaeschke, Franziska, Schlegel, Patrick, Bösmüller, Hans, Quintanilla-Fend, Leticia, Ebinger, Martin, Lang, Peter, Handgretinger, Rupert, Feuchtinger, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363558/
https://www.ncbi.nlm.nih.gov/pubmed/27708227
http://dx.doi.org/10.18632/oncotarget.12357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363558/
https://www.ncbi.nlm.nih.gov/pubmed/27708227
http://dx.doi.org/10.18632/oncotarget.12357

Ejemplares similares